By Chardelle Prevatt The opportunistic pathogen Pseudomonas aeruginosa causes severe infections in patients with cystic fibrosis. In patients with compromised immune defenses, these infections can lead to serious complications, reduced quality of life, and high mortality rates. P. aeruginosa infections are challenging to treat since the bacteria coat themselves in a sticky slime or biofilm that protects them against antibiotics. […]
Category: Network News
GlycoNet scientist at McMaster finds potential new antibiotic use for old drug
By Chris Dall Early last week, the World Health Organization (WHO) released a list of 12 priority pathogens for which new antibiotics are urgently needed. The list was dominated by gram-negative bacteria, which have become resistant to multiple classes of antibiotics. Although gram-negative bacteria have emerged as a major public health threat in part […]
GlycoNet scientists study bacterial glycan synthesis and chain length control
GlycoNet team outlines one of the fundamental processes by which bacteria determine the composition and chain length of polysaccharides.
U of M based GlycoNet investigators identify novel anti-cancer agents
GlycoNet scientists, Drs. Frank Schweizer and Gilbert Arthur, together with a team of University of Manitoba (U of M) researchers, have identified a unique way to potentially treat and cure cancer, using carbohydrate-based antitumor agents.
GlycoNet immuno-oncology workshop and panel discussion
Join us in discussing the role of glycomics in immuno-oncology Date: Wednesday, May 10, 2017 Time: 1:00pm – 5:00pm (MST) Venue: The Banff Park Lodge 222 Lynx Street, Banff, Alberta, Canada T1L 1K5 Free registration is now open! Invited Speakers Dr. Todd Lowary, GlycoNet Dr. Zafrira Avnur, Quark Venture Dr. Nai-Kong Cheung, Memorial Sloan Kettering Cancer Center Dr. James Dennis, University […]
GlycoNet researchers awarded US$600,000 grant from U.S. DoD for breast cancer project
Drs. Karla Williams, Ann Chambers, and two GlycoNet scientists Drs. Mark Nitz and Hon Leong—received a US$600,000 award from the U.S. Department of Defense (DoD) to expand their breast cancer research.
GlycoNet and the U of A’s CMASTE expand glycomics-related curricula
Teachers immersed themselves in the research labs, collaborating with GlycoNet principal investigators and lab members.
GlycoNet scientists attend first annual trilateral glycomics symposium
The meeting developed closer ties between the glycomics communities in Canada, Australia, and Taiwan.
GlycoNet scientist to lead innovative study on treatment of periodontal disease
Network Investigators are studying innovative treatment options for periodontal diseases, specifically exploring ways to disrupt plaques to increase the effectiveness of treating harmful oral bacteria.
Introducing a novel glycomics core service—48Hour Discovery
This accelerated service is designed to help academia and industry in molecular discovery in the areas of therapeutics, diagnostics, and probe development.